Stalevo

Medicinal product

(Invented) name

Stalevo

Active substance (s)

Levodopa/Karbidopa/Entakaponas

Strength

100 mg/25 mg/200 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

N04BA03, Levodopa, decarboxylase inhibitor and COMT inhibitor

Marketing authorisation holder

Orion Corporation, Suomija

Date of authorisation

2003-10-17

Date of renewal

Documents

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

10a

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To
28330	30858	1030858	buteliukas	N10	Receptinis	EU/1/03/260/005	Netiekiama	-	-	No	-	-
28331	5016	1005016	buteliukas	N30	Receptinis	EU/1/03/260/006	Netiekiama	-	-	No	-	-
28332	4404	1004404	buteliukas	N100	Receptinis	EU/1/03/260/007	Tiekiama	-	-	No	-	-
28333	30859	1030859	buteliukas	N250	Receptinis	EU/1/03/260/008	Netiekiama	-	-	No	-	-
28334	30860	1030860	buteliukas	N175	Receptinis	EU/1/03/260/014	Netiekiama	-	-	No	-	-
28335	30861	1030861	buteliukas	N130	Receptinis	EU/1/03/260/017	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2003-10-17	Registruotas